Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Experimental Hematology

• Publication date

  2008-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.exphem.2008.02.014PMID 18400362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hodgkin's reed-sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4[+]CD25[+]Foxp3[+] T cells and CD4[+] cytotoxic T lymphocytes from CD4[+] naive T cells

  2008cited by this paper
• Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphoma

  2007cited by this paper
• Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma.

  2007cited by this paper
• Hodgkin's Reed‐Sternberg cell line (KM‐H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells

  2007cited by this paper
• Prognostic Significance of Cell Proliferation and Apoptosis-Regulating Proteins in Epstein-Barr Virus Positive and Negative Pediatric Hodgkin Lymphoma

  2007cited by this paper
• BLIMP‐1 is a target of cellular stress and downstream of the unfolded protein response

  2006cited by this paper
• Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications.

  2006cited by this paper
• Molecular alterations of cells resistant to platinum drugs: role of PKCalpha.

  2006cited by this paper
• Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.

  2006cited by this paper
• Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors.

  2006cited by this paper
• Detection and Functional Analysis of CD8+ T Cells Specific for PRAME: a Target for T-Cell Therapy

  2006cited by this paper
• Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.

  2006cited by this paper
• Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis

  2006cited by this paper
• The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.

  2006cited by this paper
• Hodgkin disease survival in Europe and the U.S.

  2006cited by this paper
• Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation.

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Outcome in Hodgkin's Lymphoma Can Be Predicted from the Presence of Accompanying Cytotoxic and Regulatory T Cells

  2005cited by this paper
• Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas.

  2005cited by this paper
• B-cell differentiation, apoptosis and proliferation in diffuse large B-cell lymphomas.

  2005cited by this paper
• Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues.

  2005cited by this paper
• Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).

  2005cited by this paper
• Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: A quantitative tissue microarray study in a large retrospective cohort of 267 patients

  2005cited by this paper
• BLIMP-1 Is a Target of Cellular Stress and Downstream of the Unfolded Protein Response.

  2005cited by this paper
• Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin's and Reed–Sternberg cells

  2004cited by this paper
• The Tumor-Associated Antigen PRAME Is Universally Expressed in High-Stage Neuroblastoma and Associated with Poor Outcome

  2004cited by this paper
• The Concept of the GPOH-HD 2003 Therapy Study for Pediatric Hodgkin's Disease: Evolution in the Tradition of the DAL/GPOH Studies

  2004cited by this paper
• Hodgkin's disease: Establishment and characterization of four in vitro cell lines

  2004cited by this paper
• Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease

  2004cited by this paper
• Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma.

  2004cited by this paper
• Functional and molecular characterization of interleukin‐2 transgenic Ewing tumor cells for in vivo immunotherapy

  2004cited by this paper
• IN VITRO DRUG SENSITIVITY AND APOPTOSIS INDUCTION IN NEWLY DIAGNOSED PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: Correlation with Overall Survival

  2004cited by this paper
• DNA Microarrays Reveal Relationship of Ewing Family Tumors to Both Endothelial and Fetal Neural Crest-Derived Cells and Define Novel Targets

  2004influential reference
• MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis.

  2004cited by this paper
• Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy

  2003influential reference
• Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

  2003cited by this paper
• Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis).

  2003cited by this paper
• Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.

  2003cited by this paper
• The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors.

  2003cited by this paper
• Hodgkin and Reed-Sternberg cell-associated autoantigen CLIP-170/restin is a marker for dendritic cells and is involved in the trafficking of macropinosomes to the cytoskeleton, supporting a function-based concept of Hodgkin and Reed-Sternberg cells.

  2002cited by this paper
• The disappearance of prognostic factors in Hodgkin's disease.

  2002cited by this paper
• Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to apo2l/trail‐induced apoptosis

  2002cited by this paper
• MYC overexpression imposes a nonimmunogenic phenotype on Epstein–Barr virus-infected B cells

  2002cited by this paper
• Relationship of XIST expression and responses of ovarian cancer to chemotherapy.

  2002cited by this paper
• Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.

  2002cited by this paper
• Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease

  2002cited by this paper
• The Role of Interleukin 13 in Classical Hodgkin Lymphoma

  2002cited by this paper
• CD40 Ligand - An Anti-Apoptotic Molecule in Hodgkin's Disease

  2001cited by this paper
• Activated Notch1 Can Transiently Substitute for EBNA2 in the Maintenance of Proliferation of LMP1-Expressing Immortalized B Cells

  2001cited by this paper
• Involvement of the X chromosome in non‐Hodgkin lymphoma

  2000cited by this paper
• Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation

  2000cited by this paper
• Spontaneous apoptosis of Reed-Sternberg and Hodgkin cells; clinical and pathological implications in patients with Hodgkin's disease.

  2000cited by this paper
• High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.

  1999cited by this paper
• Differential Effect of B Lymphocyte–induced Maturation Protein (Blimp-1) Expression on Cell Fate during B Cell Development

  1998cited by this paper
• IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.

  1998cited by this paper
• X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status.

  1997cited by this paper
• Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1.

  1997cited by this paper
• X chromosome inactivation is mediated by Xist RNA stabilization.

  1997cited by this paper
• Chromosome mapping and expression of the human interleukin-13 receptor.

  1997cited by this paper
• Chromosome mapping and expression of the human interleukin-13 receptor

  1997cited by this paper
• Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells.

  1996cited by this paper
• The human X-inactivation centre is not required for maintenance of X-chromosome inactivation

  1994cited by this paper
• Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors

  1993cited by this paper
• Hodgkin's disease derived cell lines: a review.

  1992cited by this paper
• Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease.

  1986influential reference
• Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles.

  1986influential reference
• Hodgkin's disease: establishment and characterization of four in vitro cell lies.

  1981cited by this paper
• Hudson et al.

  1977cited by this paper

• Systematic Review of Comparative Transcriptomic Studies of Cellular Resistance to Genotoxic Stress.

  2023cites this paper
• IL5RA as an immunogenic cell death-related predictor in progression and therapeutic response of multiple myeloma

  2023cites this paper
• JMJD2C mediates the MDM2/p53/IL5RA axis to promote CDDP resistance in uveal melanoma

  2022cites this paper
• The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer

  2020cites this paper
• Melittin Increases Cisplatin Sensitivity and Kills KM-H2 and L-428 Hodgkin Lymphoma Cells

  2020cites this paper
• Expression of A New Endogenous Retrovirus-Associated Transcript in Hodgkin Lymphoma Cells

  2019cites this paper
• WebHERV: A Web Server for the Computational Investigation of Gene Expression Associated With Endogenous Retrovirus-Like Sequences

  2018cites this paper
• Clinical Significance of the PRAME Gene Expression in Oncohematological Diseases

  2018cites this paper
• Identification of crucial genes and prediction of small molecules for multidrug resistance of Hodgkin’s lymphomas

  2018cites this paper
• Characterization of Alstrom Syndrome 1 (ALMS1) Transcript Variants in Hodgkin Lymphoma Cells

  2017cites this paper
• CONCORD biomarker prediction for novel drug introduction to different cancer types

  2017cites this paper
• 1 Recent Insights into the Biology of Hodgkin ' s Lymphoma

  2017cites this paper
• Stimulation of the hypoxia pathway modulates chemotherapy resistance in Hodgkin’s lymphoma cells

  2016cites this paper
• Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins.

  2016cites this paper
• Glutathione-S-transferases and Chemotherapy Resistance of Hodgkin's Lymphoma Cell Lines.

  2016cites this paper
• Prognostic Biomarkers for Hodgkin Lymphoma

  2015influential citation
• Immunostimulation by OX40 Ligand Transgenic Ewing Sarcoma Cells

  2015cites this paper
• PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma

  2015cites this paper
• Mixed Lineage Leukemia 5 (MLL5) identified as disease contributing gene by single cell transcriptome analysis of classical pediatric and adult Hodgkin lymphoma

  2015cites this paper
• A short treatise concerning a musical approach for the interpretation of gene expression data

  2015cites this paper
• Expression of Dual-Specificity Phosphatase 5 Pseudogene 1 (DUSP5P1) in Tumor Cells

  2014cites this paper
• Circulating tumor cells in Hodgkin's lymphoma - a review of the spread of HL tumor cells or their putative precursors by lymphatic and hematogenous means, and their prognostic significance.

  2014cites this paper
• Impact of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine resistance of Hodgkin's lymphoma cells.

  2014cites this paper
• Biomarker signatures for predicting drug response in hodkin's lymphoma

  2014cites this paper
• Curcuma Contra Cancer? Curcumin and Hodgkin’s Lymphoma

  2013cites this paper
• Knock-Down of PRAME Increases Retinoic Acid Signaling and Cytotoxic Drug Sensitivity of Hodgkin Lymphoma Cells

  2013influential citation
• Expression and Regulation of the Endogenous Retrovirus 3 in Hodgkin’s Lymphoma Cells

  2013cites this paper
• The mitochondrial transporter SLC25A43 is frequently deleted and may influence cell proliferation in HER2-positive breast tumors

  2012cites this paper
• Histone deacetylase inhibition restores cisplatin sensitivity of Hodgkin's lymphoma cells.

  2012cites this paper
• Hodgkin’s lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune responses

  2012influential citation
• Recent Insights into the Biology of Hodgkin's Lymphoma

  2012cites this paper
• Down-regulation of achaete-scute complex homolog 1 (ASCL1) in neuroblastoma cells induces up-regulation of insulin-like growth factor 2 (IGF2)

  2011cites this paper
• Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells

  2011cites this paper
• Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies

  2011cites this paper
• Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma.

  2011cites this paper
• Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome.

  2010cites this paper
• Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia

  2010cites this paper
• Depsipeptide induces cell death in Hodgkin lymphoma-derived cell lines.

  2009cites this paper
• New treatment strategies for Hodgkin's lymphoma.

  2009cites this paper
• Expression of CD4 on Epstein–Barr Virus‐immortalized B Cells

  2009cites this paper
• Rare association of Hodgkin lymphoma, Graves’ disease and myasthenia gravis complicated by post-radiation neurofibrosarcoma: coincidence or genetic susceptibility?

  2009cites this paper